The panzootic potential of SARS-CoV-2

被引:1
|
作者
Mabry, Makenzie E. [1 ]
Fanelli, Angela [2 ]
Mavian, Carla [3 ,4 ]
Lorusso, Alessio [5 ]
Manes, Costanza [6 ,7 ]
Soltis, Pamela S. [1 ]
Capua, Ilaria [7 ,8 ]
机构
[1] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA
[2] Univ Bari, Dept Vet Med, Valenzano, Bari, Italy
[3] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA
[4] Univ Florida, Dept Pathol, Gainesville, FL USA
[5] Ist Zooprofilatt Sperimentale Abruzzo & Molise G C, Teramo, Italy
[6] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA
[7] Univ Florida, One Hlth Ctr Excellence, Gainesville, FL USA
[8] Johns Hopkins Univ, Sch Adv Int Studies, Bologna, Italy
基金
美国国家科学基金会;
关键词
SARS-CoV-2; evolution; mammals; panzootic; mutations; DELTA VARIANT; INFECTION; CORONAVIRUS; SUSCEPTIBILITY; ACE2; TRANSMISSION; MACAQUES; COVID-19; HAMSTERS; RECEPTOR;
D O I
10.1093/biosci/biad102
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Each year, SARS-CoV-2 is infecting an increasingly unprecedented number of species. In the present article, we combine mammalian phylogeny with the genetic characteristics of isolates found in mammals to elaborate on the host-range potential of SARS-CoV-2. Infections in nonhuman mammals mirror those of contemporary viral strains circulating in humans, although, in certain species, extensive viral circulation has led to unique genetic signatures. As in other recent studies, we found that the conservation of the ACE2 receptor cannot be considered the sole major determinant of susceptibility. However, we are able to identify major clades and families as candidates for increased surveillance. On the basis of our findings, we argue that the use of the term panzootic could be a more appropriate term than pandemic to describe the ongoing scenario. This term better captures the magnitude of the SARS-CoV-2 host range and would hopefully inspire inclusive policy actions, including systematic screenings, that could better support the management of this worldwide event.
引用
收藏
页码:814 / 829
页数:16
相关论文
共 50 条
  • [21] Periodontal pockets: A potential reservoir for SARS-CoV-2?
    Badran, Zahi
    Gaudin, Alexis
    Struillou, Xavier
    Amador, Gilles
    Soueidan, Assem
    MEDICAL HYPOTHESES, 2020, 143
  • [22] Potential drawbacks of SARS-CoV-2 seroprevalence surveys
    Lippi, G.
    JOURNAL OF HOSPITAL INFECTION, 2021, 110 : 206 - 206
  • [23] Potential role of skin in SARS-CoV-2 infection
    Chudakova, D.
    Klopot, A.
    Shi, B.
    Bhalla, P.
    Tsoi, L. C.
    White, B. E. Perez
    Budunova, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S147 - S147
  • [24] Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2
    L. A. Oleinik
    P. G. Madonov
    M. B. Pykhtina
    Molecular Biology, 2023, 57 : 291 - 298
  • [25] Potential threat of SARS-CoV-2 in coastal waters
    Guo, Weijun
    Cao, Yimeng
    Kong, Xiangpeng
    Kong, Shujun
    Xu, Tiaojian
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2021, 220
  • [26] Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
    Alkotaji, Myasar
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (06)
  • [27] Unravelling the Potential of Anticancer Drugs for SARS-CoV-2
    Low, Zheng Yao
    Wong, Ka Heng
    Yip, Ashley Jia Wen
    Liew, Hern Liang
    Farouk, Isra Ahmad
    Lal, Sunil Kumar
    Choo, Wee Sim
    CURRENT PHARMACOLOGY REPORTS, 2025, 11 (01)
  • [28] Recent insights of SARS-CoV-2 potential inhibitors
    Faheem, Mohd
    Singh, Vinay Kumar
    Srivastava, Abhishek
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2022, 6 (01): : 21 - 32
  • [29] Potential zoonotic sources of SARS-CoV-2 infections
    Jo, Wendy K.
    de Oliveira-Filho, Edmilson Ferreira
    Rasche, Andrea
    Greenwood, Alex D.
    Osterrieder, Klaus
    Drexler, Jan Felix
    TRANSBOUNDARY AND EMERGING DISEASES, 2021, 68 (04) : 1824 - 1834
  • [30] Potential SARS-CoV-2 main protease inhibitors
    Banerjee, Riddhidev
    Perera, Lalith
    Tillekeratne, L. M. Viranga
    DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816